<?xml version="1.0" encoding="UTF-8"?>
<contrib-group>
 <contrib contrib-type="author" id="au1">
  <name>
   <surname>Petrosillo</surname>
   <given-names>N.</given-names>
  </name>
  <email>nicola.petrosillo@inmi.it</email>
  <xref rid="aff1" ref-type="aff">1</xref>
  <xref rid="cor1" ref-type="corresp">∗</xref>
 </contrib>
 <contrib contrib-type="author" id="au2">
  <name>
   <surname>Viceconte</surname>
   <given-names>G.</given-names>
  </name>
  <xref rid="aff2" ref-type="aff">2</xref>
 </contrib>
 <contrib contrib-type="author" id="au3">
  <name>
   <surname>Ergonul</surname>
   <given-names>O.</given-names>
  </name>
  <xref rid="aff3" ref-type="aff">3</xref>
  <xref rid="aff4" ref-type="aff">4</xref>
 </contrib>
 <contrib contrib-type="author" id="au4">
  <name>
   <surname>Ippolito</surname>
   <given-names>G.</given-names>
  </name>
  <xref rid="aff1" ref-type="aff">1</xref>
 </contrib>
 <contrib contrib-type="author" id="au5">
  <name>
   <surname>Petersen</surname>
   <given-names>E.</given-names>
  </name>
  <xref rid="aff5" ref-type="aff">5</xref>
  <xref rid="aff6" ref-type="aff">6</xref>
  <xref rid="aff7" ref-type="aff">7</xref>
 </contrib>
 <aff id="aff1">
  <label>1)</label>National Institute for Infectious Diseases ‘L. Spallanzani’, IRCCS, Rome, Italy
 </aff>
 <aff id="aff2">
  <label>2)</label>University ‘Federico II’, Department of Clinical Medicine and Surgery, Naples, Italy
 </aff>
 <aff id="aff3">
  <label>3)</label>Koc University, School of Medicine, Istanbul, Turkey
 </aff>
 <aff id="aff4">
  <label>4)</label>ESCMID Executive Committee, Switzerland
 </aff>
 <aff id="aff5">
  <label>5)</label>Directorate General for Disease Surveillance and Control, Min of Health, Muscat, Oman
 </aff>
 <aff id="aff6">
  <label>6)</label>ESCMID Emerging Infections Task Force, ESCMID, Basel, Switzerland
 </aff>
 <aff id="aff7">
  <label>7)</label>Institute for Clinical Medicine, Faculty of Health Sciences, University of Aarhus, Denmark
 </aff>
</contrib-group>
